Characterization of a novel mucopolysaccharidosis type II mouse model and recombinant AAV2/8 vector-mediated gene therapy

  • Jung, Sung-Chul; 
  • Park, Eun-Sook; 
  • Choi, Eun Nam; 
  • Kim, Chi Hwa; 
  • Kim, Su Jin; 
  • 외 1명
Citations

WEB OF SCIENCE

38
Citations

SCOPUS

38

초록

Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is an X-linked inherited disorder caused by a deficiency of the enzyme iduronate-2-sulfatase (IDS), which results in the lysosomal accumulation of glycosaminoglycans (GAG) such as dermatan and heparan sulfate. Here, we report the generation of IDS knockout mice, a model of human MPS II, and an analysis of the resulting phenotype. We also evaluated the effect of gene therapy with a pseudotyped, recombinant adeno-associated virus 2/8 vector encoding the human IDS gene (rAAV-hIDS) in IDS-deficient mice. IDS activity and GAG levels were measured in serum and tissues after therapy. Gene therapy completely restored IDS activity in plasma and tissue of the knockout mice. The rescued enzymatic activity completely cleared the accumulated GAGs in all the tissues analyzed. This model can be used to explore the therapeutic potential of IDS replacement and other strategies for the treatment of MPS II. Additionally, AAV2/8 vectors have promising future clinical applications for the treatment of patients with MPS II.

키워드

adeno-associated virus; gene therapy; hunter syndrome; iduronate-2-sulfatase; MPS II mouse model; BONE-MARROW-TRANSPLANTATION; ENZYME-REPLACEMENT THERAPY; HUNTER-SYNDROME; TARGETED DISRUPTION; ADENOASSOCIATED VIRUS; CELL TRANSPLANTATION; ADENOVIRUS VECTORS; IMMUNE-RESPONSE; IN-VITRO; DISEASE
제목
Characterization of a novel mucopolysaccharidosis type II mouse model and recombinant AAV2/8 vector-mediated gene therapy
저자
Jung, Sung-Chul; Park, Eun-Sook; Choi, Eun Nam; Kim, Chi Hwa; Kim, Su Jin; Jin, Dong-Kyu
DOI
10.1007/s10059-010-0083-2
발행일
2010-07
유형
Article
저널명
Molecules and Cells
권
30
호
1
페이지
13 ~ 18